$RKDA
Arcadia Biosciences, Inc.

2020 Q1 Form 10-Q Financial Statement

#000156459020025131 Filed on May 13, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $309.0K $158.0K
YoY Change 95.57% -26.17%
Cost Of Revenue $70.00K $60.00K
YoY Change 16.67% 66.67%
Gross Profit $240.0K $100.0K
YoY Change 140.0% -43.82%
Gross Profit Margin 77.67% 63.29%
Selling, General & Admin $3.723M $2.812M
YoY Change 32.4% 7.29%
% of Gross Profit 1551.25% 2812.0%
Research & Development $2.244M $1.505M
YoY Change 49.1% 7.81%
% of Gross Profit 935.0% 1505.0%
Depreciation & Amortization $74.00K $34.00K
YoY Change 117.65% -32.0%
% of Gross Profit 30.83% 34.0%
Operating Expenses $6.099M $4.376M
YoY Change 39.37% 7.97%
Operating Profit -$5.790M -$4.218M
YoY Change 37.27% 9.87%
Interest Expense $3.000K -$8.500M
YoY Change -100.04% 347.37%
% of Operating Profit
Other Income/Expense, Net $72.00K $120.0K
YoY Change -40.0% 215.79%
Pretax Income $2.440M -$12.59M
YoY Change -119.38% 18.72%
Income Tax $17.00K $19.00K
% Of Pretax Income 0.7%
Net Earnings $2.525M -$12.61M
YoY Change -120.02% 18.81%
Net Earnings / Revenue 817.15% -7982.28%
Basic Earnings Per Share $0.29 -$2.64
Diluted Earnings Per Share $0.29 -$2.64
COMMON SHARES
Basic Shares Outstanding 8.651M 4.777M
Diluted Shares Outstanding 8.675M 4.777M

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $16.02M $17.79M
YoY Change -9.95% -12.88%
Cash & Equivalents $12.97M $10.44M
Short-Term Investments $3.050M $7.360M
Other Short-Term Assets $1.460M $510.0K
YoY Change 186.27% 21.43%
Inventory $5.970M $187.0K
Prepaid Expenses
Receivables $310.0K $79.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $23.76M $18.57M
YoY Change 27.98% -12.64%
LONG-TERM ASSETS
Property, Plant & Equipment $8.190M $460.0K
YoY Change 1680.43% 64.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $300.0K $730.0K
YoY Change -58.9% 10328.57%
Total Long-Term Assets $8.490M $3.385M
YoY Change 150.81% 150.93%
TOTAL ASSETS
Total Short-Term Assets $23.76M $18.57M
Total Long-Term Assets $8.490M $3.385M
Total Assets $32.25M $21.95M
YoY Change 46.92% -2.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.00K $10.00K
YoY Change 100.0%
Accrued Expenses $530.0K $570.0K
YoY Change -7.02%
Deferred Revenue $56.00K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $30.00K $0.00
YoY Change
Total Short-Term Liabilities $5.808M $2.970M
YoY Change 95.56% -2.04%
LONG-TERM LIABILITIES
Long-Term Debt $130.0K $0.00
YoY Change
Other Long-Term Liabilities $14.09M $3.000M
YoY Change 369.67% 0.0%
Total Long-Term Liabilities $14.22M $3.000M
YoY Change 374.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.808M $2.970M
Total Long-Term Liabilities $14.22M $3.000M
Total Liabilities $21.23M $21.32M
YoY Change -0.41% -2.8%
SHAREHOLDERS EQUITY
Retained Earnings -$191.0M
YoY Change 8.82%
Common Stock $191.6M
YoY Change 8.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.02M $630.0K
YoY Change
Total Liabilities & Shareholders Equity $32.25M $21.95M
YoY Change 46.92% -2.87%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $2.525M -$12.61M
YoY Change -120.02% 18.81%
Depreciation, Depletion And Amortization $74.00K $34.00K
YoY Change 117.65% -32.0%
Cash From Operating Activities -$9.270M -$3.969M
YoY Change 133.56% 51.66%
INVESTING ACTIVITIES
Capital Expenditures $778.0K $88.00K
YoY Change 784.09% 166.67%
Acquisitions
YoY Change
Other Investing Activities $13.91M $2.510M
YoY Change 454.18% -35.81%
Cash From Investing Activities $13.13M $2.422M
YoY Change 442.11% -37.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 696.0K -13.00K
YoY Change -5453.85% -100.13%
NET CHANGE
Cash From Operating Activities -9.270M -3.969M
Cash From Investing Activities 13.13M 2.422M
Cash From Financing Activities 696.0K -13.00K
Net Change In Cash 4.556M -1.560M
YoY Change -392.05% -113.81%
FREE CASH FLOW
Cash From Operating Activities -$9.270M -$3.969M
Capital Expenditures $778.0K $88.00K
Free Cash Flow -$10.05M -$4.057M
YoY Change 147.67% 53.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
24000
CY2019Q4 rkda Common Stock Warrant Liabilities
CommonStockWarrantLiabilities
14936000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2000000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
611000
CY2019Q4 us-gaap Liabilities
Liabilities
24248000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1497000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
49000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
214826000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32574000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8646149
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8646149
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
42000
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
526000
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
306000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5808000
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-207171000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
7705000
CY2020Q1 us-gaap Minority Interest
MinorityInterest
1208000
CY2019Q4 us-gaap Minority Interest
MinorityInterest
621000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12223000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8326000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32248000
CY2020Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
130000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2244000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1505000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2812000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
4376000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4218000
CY2020Q1 us-gaap Interest Expense
InterestExpense
3000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
120000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
2440000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-12593000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
2423000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-12612000
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-102000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
2525000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-12612000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8651213
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4776540
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8674610
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4776540
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
14000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
772000
CY2020Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
689000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12815000
CY2019Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
8000
CY2020Q1 us-gaap Depreciation
Depreciation
74000
CY2019Q1 us-gaap Depreciation
Depreciation
34000
CY2020Q1 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
223000
CY2019Q1 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
172000
CY2020Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
39000
CY2019Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
39000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
772000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
422000
CY2020Q1 us-gaap Inventory Write Down
InventoryWriteDown
59000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-293000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-86000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4145000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-39000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
748000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-200000
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
15000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
227000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-538000
CY2020Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-24000
CY2019Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-16000
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-25000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2422000
CY2019Q1 rkda Payments Of Deferred Offering Costs
PaymentsOfDeferredOfferingCosts
5000
CY2020Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
7000
CY2020Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
14000
CY2019Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
8000
CY2020Q1 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
689000
CY2019Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
13000
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-40000
CY2020Q1 rkda Increase Decrease In Operating Lease Payments
IncreaseDecreaseInOperatingLeasePayments
-184000
CY2019Q1 rkda Increase Decrease In Operating Lease Payments
IncreaseDecreaseInOperatingLeasePayments
-172000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9270000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3969000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
778000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
88000
CY2020Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1292000
CY2019Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
6690000
CY2020Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
15200000
CY2019Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
9200000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
13130000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
696000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4556000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1560000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8417000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11998000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12973000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10438000
CY2019Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
2000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
3000
CY2020Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
37000
CY2019Q1 rkda Offering Costs Incurred During Noncash Or Partial Noncash Transaction Included In Accounts Payable And Accrued Expenses
OfferingCostsIncurredDuringNoncashOrPartialNoncashTransactionIncludedInAccountsPayableAndAccruedExpenses
7000
CY2019Q1 rkda Deferred Stock Offering Costs Incurred During Noncash Or Partial Noncash Transaction Included In Accounts Payable And Accrued Expenses
DeferredStockOfferingCostsIncurredDuringNoncashOrPartialNoncashTransactionIncludedInAccountsPayableAndAccruedExpenses
18000
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3836000
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2328000
CY2019 us-gaap Profit Loss
ProfitLoss
-28900000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17200000
CY2019Q1 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2020Q1 rkda Inventory Raw Materials Current And Non Current
InventoryRawMaterialsCurrentAndNonCurrent
240000
CY2019Q4 rkda Inventory Raw Materials Current And Non Current
InventoryRawMaterialsCurrentAndNonCurrent
67000
CY2020Q1 rkda Inventory Goods In Process Current And Non Current
InventoryGoodsInProcessCurrentAndNonCurrent
2684000
CY2019Q4 rkda Inventory Goods In Process Current And Non Current
InventoryGoodsInProcessCurrentAndNonCurrent
188000
CY2020Q1 rkda Inventory Finished Goods Current And Non Current
InventoryFinishedGoodsCurrentAndNonCurrent
3320000
CY2019Q4 rkda Inventory Finished Goods Current And Non Current
InventoryFinishedGoodsCurrentAndNonCurrent
1903000
CY2020Q1 rkda Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
6244000
CY2019Q4 rkda Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
2158000
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
14078000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
14078000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
24678000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
24679000
CY2020Q1 rkda Available For Sale Securities Continuous Unrealized Loss Position For More Than Three Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionForMoreThanThreeMonthsAccumulatedLoss
0
CY2020Q1 rkda Number Of Fixed Income Securities In Unrealized Loss Position
NumberOfFixedIncomeSecuritiesInUnrealizedLossPosition
0
CY2020Q1 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
0
CY2020Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
14078000
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
24679000
CY2020Q1 us-gaap Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
318000
CY2019Q1 us-gaap Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
243000
CY2020Q1 us-gaap Lessee Operating Sublease Option To Extend
LesseeOperatingSubleaseOptionToExtend
lease amendment that provides for additional office space in Davis, CA, and extends the term through April 2025, with one option to renew for an additional five-year term. The Company expects to exercise its options to renew, and in accordance with ASC 842, accounted for the amendment and expected renewal as a lease modification and remeasured the operating lease liability
CY2020Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2020Q1 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
Some leases (the Davis office, warehouse, greenhouse and a copy machine) include one or more options to renew, with renewal terms that can extend the lease term from one to six years.
CY2020Q1 rkda Operating Lease Assets
OperatingLeaseAssets
5654000
CY2019Q4 rkda Operating Lease Assets
OperatingLeaseAssets
1963000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
5838000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
55441
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
23007
CY2019Q3 us-gaap Debt Instrument Term
DebtInstrumentTerm
P5Y
CY2020Q1 us-gaap Debt Instrument Term
DebtInstrumentTerm
P5Y
CY2019Q3 rkda Notes Payable Maturity Year
NotesPayableMaturityYear
2024
CY2020Q1 rkda Notes Payable Maturity Year
NotesPayableMaturityYear
2024
CY2020Q1 us-gaap Notes Payable
NotesPayable
161000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2108000
CY2020Q1 us-gaap Lease Cost
LeaseCost
292000
CY2019Q1 us-gaap Lease Cost
LeaseCost
208000
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y10M24D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.065
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.070
CY2020Q1 rkda Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
2
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
661701
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
290000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
873253
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
861245
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
414031
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.60
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.91
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.25
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
45.62
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.46
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
16.60
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
27.22
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
305000
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1900000
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M12D
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
7500
CY2020Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4349001
CY2020Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
8.99
CY2020Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08
CY2020Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0764
CY2020Q1 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
500000
CY2020Q1 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
750000
CY2020Q1 us-gaap Contractual Obligation
ContractualObligation
1250000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2525000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12612000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.64
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2525000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-12612000
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1345
CY2020Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
22052
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.64

Files In Submission

Name View Source Status
0001564590-20-025131-index-headers.html Edgar Link pending
0001564590-20-025131-index.html Edgar Link pending
0001564590-20-025131.txt Edgar Link pending
0001564590-20-025131-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rkda-10q_20200331.htm Edgar Link pending
rkda-20200331.xml Edgar Link completed
rkda-20200331.xsd Edgar Link pending
rkda-20200331_cal.xml Edgar Link unprocessable
rkda-20200331_def.xml Edgar Link unprocessable
rkda-20200331_lab.xml Edgar Link unprocessable
rkda-20200331_pre.xml Edgar Link unprocessable
rkda-ex311_8.htm Edgar Link pending
rkda-ex312_9.htm Edgar Link pending
rkda-ex321_7.htm Edgar Link pending
rkda-ex322_6.htm Edgar Link pending
Show.js Edgar Link pending